Pooja Sudarshan

Ms. Sudarshan’s recent representative experience includes:

• Represented Onera Health in its Series A preferred stock financing lead by investors Jazz Pharmaceuticals, Belgium based imec.XPand and BOM Brabant Ventures.*
• Represented a public molecular diagnostics company in their investment in and collaboration arrangement with a private biosciences company.*
• Represented a 3D cell culture technology company in their preferred stock financing from a Silicon Valley based venture capital firm.*
• Represented a Silicon Valley based life sciences company in its sale to a public Japanese company.*
• Advised on the separation of a public Canadian health care services company in into two public companies traded on the TSX Venture Exchange via a spin-off transaction.*
• Represented a public Canadian health care services company in several acquisitions of US based distributed healthcare services companies.*
• Represented a public Canadian health care services company in a Bought-Deal private placement with a syndicate of Canadian investment firms.*
• Represented and advised an immunoassay services life-sciences company in its convertible note financing transaction.*
• Represented ImmuPharma PLC (LON: IMM) in entering into an exclusive license and development agreement and trademark license agreement for Lupuzor with Georgia, USA based Avion Pharmaceuticals.*
• Represented TherapeuticsMD (NASDAQ: TXMD) in entering into a license and supply agreement with Theramex.*